0001628280-24-001281.txt : 20240112
0001628280-24-001281.hdr.sgml : 20240112
20240112185115
ACCESSION NUMBER: 0001628280-24-001281
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240111
FILED AS OF DATE: 20240112
DATE AS OF CHANGE: 20240112
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: HIBBS KATHY L
CENTRAL INDEX KEY: 0001267487
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39587
FILM NUMBER: 24533187
MAIL ADDRESS:
STREET 1: C/O VIROLOGIC
STREET 2: 345 OYSTER POINT BLVD
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: 23andMe Holding Co.
CENTRAL INDEX KEY: 0001804591
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 871240344
FISCAL YEAR END: 0331
BUSINESS ADDRESS:
STREET 1: 349 OYSTER POINT BOULEVARD
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: (650) 938-6300
MAIL ADDRESS:
STREET 1: 349 OYSTER POINT BOULEVARD
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
FORMER COMPANY:
FORMER CONFORMED NAME: VG Acquisition Corp.
DATE OF NAME CHANGE: 20200915
FORMER COMPANY:
FORMER CONFORMED NAME: Virgin Group Acquisition Corp.
DATE OF NAME CHANGE: 20200909
FORMER COMPANY:
FORMER CONFORMED NAME: Bleecker Street Acquisition Corp.
DATE OF NAME CHANGE: 20200225
4
1
wk-form4_1705103465.xml
FORM 4
X0508
4
2024-01-11
0
0001804591
23andMe Holding Co.
ME
0001267487
HIBBS KATHY L
C/O 23ANDME HOLDING CO.
349 OYSTER POINT BLVD
SOUTH SAN FRANCISCO
CA
94080
0
1
0
0
Chief Administrative Officer
1
Class A Common Stock
2024-01-11
4
M
0
38548
0.42
A
1318897
D
Class A Common Stock
2024-01-11
4
S
0
38548
0.7155
D
1280349
D
Stock Option (Right to Buy)
0.42
2024-01-11
4
M
0
38548
0
D
2024-05-04
Class A Common Stock
38548
308387
D
The sale reported on this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 9, 2023.
The sale price reported in Column 4 of Table 1 represents the weighted average sale price of the shares sold ranging from $0.6851 to $0.7430. Upon request by the staff of the Securities and Exchange commission, the Issuer, or a security holder of the Issuer, the Reporting Person will provide
full information regarding the number of shares sold at each separate price.
The stock options vested 25% after 12 months of service and on a pro rata basis (in remaining 1/48 installments) over the following 36 months of service beginning on April 1, 2014.
/s/ Kathy Hibbs
2024-01-12